Literature DB >> 20153491

Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications.

Sridevi Devaraj1, Ishwarlal Jialal, Jung-Mi Yun, Andrew Bremer.   

Abstract

Type 1 diabetes mellitus (T1DM) is associated with increased microvascular complications and is a proinflammatory state. The toll-like receptors (TLRs) are pattern recognition receptors on monocytes and important in atherosclerosis. We have shown increased TLR2 and TLR4 expression on monocytes of T1DM compared with controls. In this report, we tested the surface expression of TLR2 and TLR4 on monocytes of T1DM patients with microvascular complications (T1DM-MV) compared with those without (T1DM) and healthy controls. The study was performed at the University of California Davis. Healthy controls (n = 31), T1DM patients (n = 31), and T1DM-MV patients (n = 34) were included. The TLR2 and TLR4 surface expression was significantly increased in T1DM-MV monocytes compared with T1DM and controls (P < .01). In addition, nuclear factor κB activity and interleukin-1β release were significantly increased in monocytes from T1DM-MV compared with T1DM (P < .005). Thus, we make the novel observation that TLR2 and TLR4 expression and signaling are increased in T1DM-MV compared with T1DM and may contribute to the accentuated proinflammatory state and complications of T1DM.
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153491      PMCID: PMC2891423          DOI: 10.1016/j.metabol.2010.01.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.

Authors:  Peter Libby; David M Nathan; Kristin Abraham; John D Brunzell; Judith E Fradkin; Steven M Haffner; Willa Hsueh; Marian Rewers; B Tibor Roberts; Peter J Savage; Sonia Skarlatos; Momtaz Wassef; Cristina Rabadan-Diehl
Journal:  Circulation       Date:  2005-06-28       Impact factor: 29.690

Review 2.  Toll-like receptors and innate immunity.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Mol Med (Berl)       Date:  2006-09       Impact factor: 4.599

Review 3.  Toll-like receptors and atherosclerosis: key contributors in disease and health?

Authors:  Adam E Mullick; Peter S Tobias; Linda K Curtiss
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Modulation of atherosclerosis in mice by Toll-like receptor 2.

Authors:  Adam E Mullick; Peter S Tobias; Linda K Curtiss
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

5.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

6.  Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.

Authors:  Sridevi Devaraj; Mohan R Dasu; Jason Rockwood; William Winter; Steven C Griffen; Ishwarlal Jialal
Journal:  J Clin Endocrinol Metab       Date:  2007-11-20       Impact factor: 5.958

7.  Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.

Authors:  Xinyan Liu; Takashi Ukai; Hiromichi Yumoto; Michael Davey; Sulip Goswami; Frank C Gibson; Caroline A Genco
Journal:  Atherosclerosis       Date:  2007-04-26       Impact factor: 5.162

8.  Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications.

Authors:  Sridevi Devaraj; Anthony T Cheung; Ishwarlal Jialal; Steven C Griffen; Danh Nguyen; Nicole Glaser; Thomas Aoki
Journal:  Diabetes       Date:  2007-08-08       Impact factor: 9.461

9.  Acute modulation of toll-like receptors by insulin.

Authors:  Husam Ghanim; Priya Mohanty; Rupali Deopurkar; Ching Ling Sia; Kelly Korzeniewski; Sanaa Abuaysheh; Ajay Chaudhuri; Paresh Dandona
Journal:  Diabetes Care       Date:  2008-06-12       Impact factor: 19.112

Review 10.  Toll-like receptor 4 in atherosclerosis.

Authors:  Hongli Li; Baogui Sun
Journal:  J Cell Mol Med       Date:  2007 Jan-Feb       Impact factor: 5.310

View more
  30 in total

1.  The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications.

Authors:  Ishwarlal Jialal; Harmeet Kaur
Journal:  Curr Diab Rep       Date:  2012-02-08       Impact factor: 4.810

2.  Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.

Authors:  Harmeet Kaur; Alexander Chien; Ishwarlal Jialal
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

3.  Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Authors:  Jodie Morris; Natasha Williams; Catherine Rush; Brenda Govan; Kunwarjit Sangla; Robert Norton; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

4.  Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.

Authors:  Sridevi Devaraj; Peter Tobias; Balakuntalam S Kasinath; Rajendra Ramsamooj; Alaa Afify; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-26       Impact factor: 8.311

Review 5.  TLR2 and TLR4 in autoimmune diseases: a comprehensive review.

Authors:  Yu Liu; Heng Yin; Ming Zhao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

6.  An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Authors:  Sandrine Levet; Julie Medina; Julie Joanou; Amandine Demolder; Nelly Queruel; Kevin Réant; Matthieu Normand; Marine Seffals; Julie Dimier; Raphaële Germi; Thomas Piofczyk; Jacques Portoukalian; Jean-Louis Touraine; Hervé Perron
Journal:  JCI Insight       Date:  2017-09-07

7.  Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling.

Authors:  Lei Zhen; De-sheng Fan; Yan Zhang; Xin-ming Cao; Li-ming Wang
Journal:  Acta Pharmacol Sin       Date:  2014-12-22       Impact factor: 6.150

8.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  Toll-like receptor expression and signaling in human diabetic wounds.

Authors:  Mohan R Dasu; Sandra J Martin
Journal:  World J Diabetes       Date:  2014-04-15

10.  Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression.

Authors:  W Li; L Jin; Y Cui; A Nie; N Xie; G Liang
Journal:  J Endocrinol Invest       Date:  2020-09-26       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.